1 Inositol un stimulator cerebral prin cresterea nivelului in cerebral.
2 Inositol (myo-Inositol) cu efect in distrofia neuroaxonala a nervului mesenteric la diabetici.
Inositol Cerebral
Inositol un stimulator cerebral
Inositol in tratamentul sindromului metabolic
1. Inositol un stimulator cerebral prin cresterea nivelului in cerebral
2. Inositol (myo-Inositol) cu efect in distrofia neuroaxonala a
nervului mesenteric la diabetici
3. Inositol (myo-Inositol) creste concentratia la plasma de eritrocite si
tesutul muscular la persoane sanatoase sau cu diabet, la functia nervului
periferic in
neuropatia
diabetica
4. Inositol (myo-Inositol) la functia nervului periferic in neuropatia diabetica
5. Inositol (myo-Inositol) la functia nervului periferic la diabet
6. Inositol (myo-Inositol) in terapia de hiperglicemie, care induce embriopatii,
Inositol ca profilaxie la malformatiile congenitale
Inositol tine glicemia
sub control in terapia de hiperglicemie
Celule cu rezistenta insulinica
7. Inositol (myo-Inositol) si neural tube
defect la urmasii cu diabet
8. Inositol (myo-Inositol) la bulimie si imbuibare
9. Inositol (myo-Inositol) in tratamentul de depresie, studiu randomizat
dublu orb placebo controlat
10. Inositol (myo-Inositol) in tratamentul de depresia bipolara
11. Inositol (myo-Inositol) cu relaxare psihica in tratamentul simptomelor
psihiatrice
12. Inositol (myo-Inositol) in bolile psihiatrice
13. Inositol (myo-Inositol) sint parte din vitamina B-complex, versus
fluvoxamina in tratamentul atacurilor de panica, studiu randomizat
dublu orb placebo controlat
14. Inositol (myo-Inositol)in tratamentul atacurilor de panica, studiu randomizat
dublu orb placebo controlat
15. Inositol (myo-Inositol) la tratamentul de obsesie compulsiva, studiu
randomizat dublu orb placebo controlat
16. Inositol (myo-Inositol)
creste serotonina care preia inhibarea obsesiei compulsive
17. Inositol (myo-Inositol) cu efect la pacienti cu psioriasis care iau
litiu, studiu randomizat dublu orb placebo controlat
18. Nivelul de Inositol (myo-Inositol) si dozajul de Litiu
19. Inositol si derivatii sai D-Pinitol plus Creatina (Creatine Monohydrate) creste capacitatea
de depozitare cu creatina musculara mai mult ca Creatina singura
20. Metabolismul si functiile Inozitolului cu fosfolipidele - Fosfatidil-inositol
Inositol un accelerator metabolic, la reducerea tesutului adipos
21. Inositol in tratamentul sindromului
metabolic si cu functie ovariana la femei
cu PCOS, studiu randomizat dublu orb placebo controlat
22. Inositol (myo-Inositol) cu efect ca factor metabolic
si functie ovariana la femei cu PCOS, studiu
randomizat dublu orb placebo controlat
Inositol
(myo-Inositol) indicat la reducerea nivelului lipidelor plasmatice, rezistenta
la insulina ca diabet zaharat cu complicatii de obezitate, hiperlipidemia
si dislipidemia, ateroscleroza, hipertensiune, bolile cardiovasculare, AIDS,
cancer, sepsis, stres, lupus si alte boli autoimune, antiinflamator, poliartrita
reumatoida, boli endocrine, sindromul ovarelor polichistice (PCOS), hiperuricemia,
cresterea activitatii atletice.
23. Inositol (myo-Inositol) un citostatic natural previne geneza cancerului pulmonar
24. Inositol (myo-Inositol) un inhibitor de cancer pulmonar
25. Inositol (myo-Inositol) si IP6 Inositol
Hexafosfat in tratamentul de cancer la ficat, reversia fenotipul malign la
linia canceroasa hepatica HepG2.
Bibliografie-Referinte:Inositol
Informatii din bibliografia electronica la tema: Nutritie si sanatate
1. Silver SM, Schroeder BM, Sterns RH. Brain uptake of myoinositol after exogenous
administration. Department of Medicine, Rochester General Hospital, University
of Rochester School of Medicine, Rochester, New York 14621, USA. J Am Soc Nephrol.
2002 May;13(5):1255-60.
2. Schmidt RE, Plurad SB, Coleman BD, Williamson JR, Tilton RG. Effects of
sorbinil, dietary myo-inositol supplementation, and insulin on resolution of
neuroaxonal
dystrophy in mesenteric nerves of streptozocin-induced diabetic rats. Department
of Pathology, Washington University School of Medicine, St. Louis, MO 63110.
Diabetes. 1991 May;40(5):574-82.
3. Gregersen G, Bertelsen B, Harbo H, Larsen
E, Andersen JR, Helles A, Schmiegelow M, Christensen JE. Oral supplementation
of myoinositol: effects on peripheral
nerve function in human diabetics and on the concentration in plasma, erythrocytes,
urine and muscle tissue in human diabetics and normals. Acta Neurol Scand.
1983 Mar;67(3):164-72.
4. Clements RS Jr, Vourganti B, Kuba T, Oh SJ, Darnell B. Dietary myo-inositol
intake and peripheral nerve function in diabetic neuropathy. Metabolism.
1979 Apr;28(4 Suppl 1):477-83.
5. Salway JG, Whitehead L, Finnegan JA, Karunanayaka A, Barnett D, Payne
RB. Effect of myo-inositol on peripheral-nerve function in diabetes. Lancet.
1978
Dec
16;2(8103):1282-4.
6. Khandelwal M, Reece EA, Wu YK, Borenstein M. Dietary myo-inositol therapy
in hyperglycemia-induced embryopathy. Department of Obstetrics, Temple
University School of Medicine, Philadelphia, Pennsylvania 19140, USA. Teratology.
1998
Feb;57(2):79-84.
7. Reece EA, Khandelwal M, Wu YK, Borenstein M. Dietary
intake of myo-inositol and neural tube defects in offspring of diabetic
rats. Department of Obstetrics,
Gynecology, and Reproductive Sciences, Temple University School of Medicine,
Philadelphia, PA 19140, USA. Am J Obstet Gynecol. 1997 Mar;176(3):536-9.
8. Gelber D, Levine J, Belmaker RH. Effect of inositol on bulimia nervosa
and binge eating. Ministry of Health Mental Health Center, Faculty of Health
Sciences,
Ben Gurion University of the Negev, P.O. Box 4600, Beersheva, Israel. Int
J Eat Disord. 2001 Apr;29(3):345-8.
9. Levine J, Barak Y, Gonzalves M, Szor H,
Elizur A, Kofman O, Belmaker RH. Double-blind, controlled trial of inositol
treatment of depression. Yehuda
Abarbanel Mental
Health Center, Bat Yam, Israel. Am J Psychiatry. 1995 May;152(5):792-4.
- Levine J, Barak Y, Kofman O, Belmaker RH. Follow-up and relapse analysis
of an inositol study of depression. Abarbanel Mental Health Center, Bat Yam,
Israel.
Isr J Psychiatry Relat Sci. 1995;32(1):14-21.
10. Chengappa KN, Levine J, Gershon S, Mallinger AG, Hardan A, Vagnucci A,
Pollock B, Luther J, Buttenfield J, Verfaille S, Kupfer DJ. Inositol as an
add-on treatment
for bipolar depression. Western Psychiatric Institute and Clinic, University
of
Pittsburgh School of Medicine, PA, USA. Bipolar Disord. 2000 Mar;2(1):47-55.
11. Benjamin J, Agam G, Levine J, Bersudsky Y, Kofman O, Belmaker RH. Inositol
treatment in psychiatry. Division of Psychiatry, Faculty of Health Sciences,
Ben Gurion
University of the Negev, Beersheva, Israel. Psychopharmacol Bull. 1995;31(1):167-75.
- Benjamin J, Agam G, Levine J, Bersudsky Y, Kofman O, Belmaker RH. Inositol
treatment in psychiatry. Division of Psychiatry, Faculty of Health Sciences,
Ben Gurion
University of the Negev, Beersheva, Israel. Psychopharmacol Bull. 1995;31(1):167-75.
Levine
J. Controlled trials of inositol in psychiatry. Ministry of Health Mental Health
Center, Faculty of Health Sciences, Ben Gurion University of
the Negev, Beersheva, Israel. Eur Neuropsychopharmacol. 1997 May;7(2):147-55.
12. Einat H, Belmaker RH. The effects of inositol treatment in animal models
of psychiatric disorders. Ministry of Health Mental Health Center,
Faculty of Health Sciences,
Ben Gurion University of the Negev, Beersheva, Israel. J Affect Disord.
2001 Jan;62(1-2):113-21.
13. Palatnik A, Frolov K, Fux M, Benjamin J. Double-blind, controlled, crossover
trial of inositol versus fluvoxamine for the treatment of panic disorder. Ministry
of Health Mental Health Center, Faculty of Health Sciences, Ben Gurion University
of the Negev, Beer-Sheba, Israel. J Clin Psychopharmacol. 2001 Jun;21(3):335-9.
14.
Benjamin J, Levine J, Fux M, Aviv A, Levy D, Belmaker RH. Double-blind, placebo-controlled,
crossover trial of inositol treatment for panic disorder.
Soroka Medical Center,
Kupat Holim Sick Fund of the Histadrut, Beersheba, Israel. Am J Psychiatry.
1995 Jul;152(7):1084-6.
15. Fux M, Levine J, Aviv A, Belmaker RH. Inositol treatment of obsessive-compulsive
disorder. Ministry of Health Mental Health Center, Faculty of Health Sciences,
Ben Gurion University of the Negev, Beersheva, Israel. Am J Psychiatry. 1996
Sep;153(9):1219-21.
16. Fux M, Benjamin J, Belmaker RH. Inositol versus placebo
augmentation of serotonin reuptake inhibitors in the treatment of obsessive-compulsive
disorder:
a double-blind
cross-over study. Int J Neuropsychopharmcol. 1999;2:193-195.
17. Allan SJ, Kavanagh GM, Herd RM, Savin JA. The effect of inositol supplements
on the psoriasis of patients taking lithium: a randomized, placebo-controlled
trial. Department of Dermatology, Victoria Hospital, Kirkcaldy, Fife, UK.
Br J Dermatol. 2004 May;150(5):966-9.
18. Grisaru N & Belmaker R: Lithium dosage and inositol
levels. Br J Psychiatry 1993; 164(1):133-134.
19. Greenwood M, Kreider RB, Rasmussen C, Almada AL, Earnest CP. D-pinitol
augments whole body creatine retention in man. J Exerc Physiol Online. 2001;4:41–47.
20. Holub
BJ. Metabolism and function of myo-inositol and inositol phospholipids. Annu
Rev Nutr. 1986;6:563-97.
21. Gerli S, Mignosa M, Di Renzo GC. Effects of
inositol on ovarian function and metabolic factors in women with PCOS: a randomized
double blind placebo-controlled
trial. Department of Obstetrics and Gynecology, Monteluce Hospital,
University of Perugia, Italy. Eur Rev Med Pharmacol Sci. 2003 Nov-Dec;7(6):151-9.
22.
Gerli S, Papaleo E, Ferrari
A, Di Renzo GC. Randomized, double blind placebo-controlled trial:
effects of myo-inositol on ovarian function and metabolic factors in
women with PCOS. Department of Obstetrics and Gynecology, Monteluce
Hospital, University of Perugia, Italy. Eur Rev Med Pharmacol Sci.
2007
Sep-Oct;11(5):347-54.
23. Wattenberg LW. Chemoprevention of pulmonary
carcinogenesis by myo-inositol. Anticancer Res. 1999 Sep-Oct;19(5A):3659-61.
24. Wattenberg L. Chalcones, myo-inositol and other novel inhibitors of pulmonary
carcinogenesis. Department of Laboratory Medicine and Pathology, University of
Minnesota, Minneapolis 55455, USA. J Cell Biochem Suppl. 1995;22:162-8.
25. Vucenik I, Tantivejkul K, Zhang ZS, Cole KE, Saied I, Shamsuddin AM. IP6
in treatment of liver cancer. I. IP6 inhibits growth and reverses transformed
phenotype
in HepG2 human liver cancer cell line. Department of Medical and Research Technology,
University of Maryland School of Medicine, Baltimore 21201, USA. Anticancer Res.
1998 Nov-Dec;18(6A):4083-90.
Inositol un stimulator cerebral prin cresterea nivelului in cerebral.
